CXCR4 regulates the early extravasation of metastatic tumor cells in vivo

Neoplasia

Volumn 11, Issue 7, 2009, Pages 651-661

  Gassmann, Peter ^a   Haier, Jörg ^a   Schlüter, Kerstin ^a   Domikowsky, Britta ^a   Wendel, Claudia ^a   Wiesner, Ulrike ^b   Kubitza, Robert ^b   Engers, Rainer ^b   Schneider, Stephan W ^a   Homey, Bernhard ^b   Müller, Anja ^b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; PROTEIN CDC42; RAC PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; EXTRAVASATION; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KUPFFER CELL; LIVER METASTASIS; LIVER SINUSOID; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; TUMOR CELL;

EID: 67650457700     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.09272     Document Type: Article

References (41)

1. Chambers AF, Groom AC, and Macdonald IC (2002). Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2, 563-572.
2. Yeatman TJ and Nicolson GL (1993). Molecular basis of tumor progression: mechanisms of organ-specific tumor metastasis. Semin Surg Oncol 9, 256-263.
3. Zlotnik A and Yoshie O (2000). Chemokines. A new classification system and their role in immunity. Immunity 12, 121-127.
4. Campbell JJ and Butcher EC (2000). Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr Opin Immunol 12, 336-341.
5. Youngs SJ, Ali SA, Taub DD, and Rees RC (1997). Chemokines induce migrational responses in human breast carcinoma cell lines. Int J Cancer 71, 257-266.
6. Robledo MM, Bartolome RA, Longo N, Rodriguez-Frade JM, Mellado M, Longo I, van Muijen GNP, Sanchez-Meteos P, and Teixido J (2001). Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells. J Biol Chem 276, 45098-45105.
7. Rubin JB, Kung AL, Klein RS, Chan JA, Sun Y, Schmidt K, Kieran MW, Luster AD, and Segal RA (2003). A small molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci USA 100, 13513-13518.
8. Chen Y, Stamatoyannopoulo G, and Song CZ (2003). Down regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro. Cancer Res 63, 4801-4804.
9. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner S, et al. (2001). Involvement of chemokine receptors in breast cancer metastases. Nature 410, 50-56.
10. Murakami T, Maki W, Cardones AR, Fang H, Kyi AT, Nestle FO, and Hwang ST (2002). Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res 62, 7328-7334.
11. Bertolini F, Dell'Agnola C, Mancuso P, Rabascio C, Alessandra B, Monestiroli S, Gobbi A, Pruneri G, and Martinelli G (2002). CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma. Cancer Res 62, 3106-3112.
12. Cardones AR, Murakami T, and Hwang ST (2003). CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via α1 integrin. Cancer Res 63, 6751-6757.
13. Kim J, Mori T, Chen SL, Amersi FF, Martinez SR, Kuo C, Turner RR, Ye X, Bilchik AJ, Morton DL, et al. (2006). Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome. Ann Surg 244, 113-120.
14. Schimanski CC, Bahre R, Gockel I, Müller A, Frerichs K, Hörner V, Teufel A, Simiantonaki N, Biesterfeld S, Wehler T, et al. (2006). Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4. Br J Cancer 95, 210-217.
15. Haier J, Korb T, Hotz B, Spiegel HU, and Senninger N (2003). An intravital model to monitor steps of metastatic tumor cell adhesion within the hepatic microcirculation. J Gastrointest Surg 7, 507-514.
16. Schlüter K, Gassmann P, Enns A, Korb T, Hemping-Bovenkerk A, Hölzen JP, and Haier J (2006). Organ-specific metastatic tumor cell adhesion and extravasation of colon carcinoma cells with different metastatic potential. Am J Pathol 169, 1064-1073.
17. Haier J, Nasralla M, and Nicolson GL (1999). Different adhesion properties of highly and poorly metastastic HT-29 colon carcinoma cells with extracellular matrix components: role of integrin expression and cytoskeletal components. Br J Cancer 80, 1867-1874.
18. Homey B, Wang W, Soto H, Buchanan ME, Wiesenborn A, Catron D, Müller A, McClanahan TK, Dieu-Nosjean MC, Orozco R, et al. (2000). Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J Immunol 164, 3465-3470.
19. Schneider SW, Sritharan CK, Geibel JP, Oberleithner H, and Jena BP (1997). Surface dynamics in living acinar cells imaged by atomic force microscopy: identification of plasma membrane structures involved in exocytosis. Proc Natl Acad Sci USA 94, 316-321.
20. Schneider SW, Matzke R, Radmacher M, and Oberleithner H (2004). Shape and volume of living aldosterone-sensitive cells imaged with atomic force microscopy. Methods Mol Biol 242, 255-279.
21. Enns A, Gassmann P, Schlueter K, Korb T, Spiegel HU, Senninger N, and Haier J (2004). Integrins can directly mediate metastatic tumor cell adhesion within liver sinusoides. J Gastrointest Surg 8, 1049-1059.
22. Rosenow F, Ossig R, Thormeyer D, Gassmann P, Schlüter K, Brunner G, Haier J, and Eble JA (2008). Integrins as antimetastatic targets of RGD-independent snake venom components in liver metastasis [corrected]. Neoplasia 10, 168-176; Erratum in: Neoplasia. 10:410.
23. Martinez-Hernendez A and Amenta PS (1993). The hepatic extracellular matrix. I. Components and distributionin normal liver. Virchows Arch A Pathol Anat Histopathol 423, 1-11.
24. Burger M, Glodek A, Hartmann T, Schmitt-Gräf A, Silberstein LE, Fuji N, Kipps TJ, and Burger JA (2003). Functional expression of CXCR 4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells. Oncogene 22, 8093-8101.
25. 1 involvement in stromal cell-derived factor-1α-promoted myeloma cell transendothelial migration and adhesion: role of cAMP and the actin cytoskeleton in adhesion. Exp Cell Res 294, 571-580.
26. 5-Integrins mediate early steps of metastasis formation. Eur J Cancer 41, 1065-1072.
27. Poston GJ (2004). Surgical strategies for colorectal liver metastases. Surg Oncol 13, 125-136.
28. Schlitt HJ, Neipp M, Weimann A, Oldhafer KJ, Schmoll E, Boecker K, Nashan B, Kubicka S, Maschek H, Tusch G, et al. (1999). Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol 17, 324-331.
29. Akashi T, Koizumi K, Tsuneyama K, Saiki I, Takano Y, and Fuse H (2008). Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer. Cancer Sci 99, 539-542.
30. Yasumoto K, Koizumi K, Kawashima A, Saitoh Y, Arita Y, Shinohara K, Minami T, Nakayama T, Sakurai H, Takahashi Y, et al. (2006). Role of the CXCL12/ CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Res 66, 2181-2187.
31. Price JT and Thompson EW (2002). Mechanisms of tumour invasion and metastasis: emerging targets for therapy. Expert Opin Ther Targets 6, 217-233.
32. Libura J, Drukala J, Majka M, Tomescu O, Navenot JM, Kucia M, Marquez L, Peiper SC, Barr FC, Janowska-Wieczorek A, et al. (2002). CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion. Neoplasia 100, 2597-2606.
33. Fernandis AZ, Prasad A, Band H, Klösel R, and Ganju RK (2004). Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Oncogene 23, 157-167.
34. Witz IP (2006). Tumor-microenvironment interactions: the selectin-selectin ligand axis in tumor-endothelium cross talk. Cancer Treat Res 130, 125-140.
35. Glinskii OV, Huxley VH, Glinsky GV, Pienta KJ, Raz A, and Glinsky VV (2005). Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs. Neoplasia 7, 522-527.
36. Kucia M, Jankowski K, Reca R, Wysoczynski M, Bandura L, Allendorf DJ, Zhang J, Ratajczak J, and Ratajczak MZ (2004). CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 35, 233-245.
37. Koshiba T, Hosotani R, Miyamoto Y, Ida J, Tsuji S, Nakajima S, Kawaguchi M, Kobayashi H, Doi R, Hori T, et al. (2000). Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res 6, 3530-3535.
38. Pelletier AJ, van der Laan LJW, Hildbrand P, Siani MA, Thompson DA, Dawson PE, Torbett BE, and Salomon DR (2000). Presentation of chemokine SDF-1α by fibronectin mediates directed migration of T cells. Blood 96, 2682-2690.
39. Miyoshi K,Wakioka T, Nishinakamura H, Kamio M, Yang L, Inoue M, Hasegawa M, Yonemitsu Y, Komiya S, and Yoshimura A (2004). The Sprouty-related protein Spred, inhibits cell motility, metastasis and Rho-mediated actin reorganisation. Oncogene 23, 5567-5576.
40. Keely PJ, Westwick JK, Whitehead IP, Der CJ, and Parise LV (1997). Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature 390, 632-636.
41. Sahai E and Marshall CJ (2003). Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol 5, 711-719.